• 1
    Doornewaard H, van der Schouw YT, van der Graaf Y, Bos AB, Habbema JDF, van den Tweel JG. The diagnostic value of computer-assisted primary cervical screening: a longitudinal cohort study. Mod Pathol. 1999; 12: 23512354.
  • 2
    Boon ME, Suurmeijer AJH. The Pap smear. 3rd ed. Amsterdam: Harwood Academic Publishers, 1996.
  • 3
    Schaafsma W. Hypothesis testing problems with the alternative restricted by a number of inequalities. Groningen: P. Noordhoff, 1966.
  • 4
    Bako G, Dewar R, Hanson J, Hill G. Population density as an indicator of urban-rural differences in cancer incidence, Alberta, Canada, 1969–1973. Can J Public Health. 1984; 75: 152156.
  • 5
    Clemensen J. Statistical studies in malignant neoplasms. III. Copenhagen: Munkgaard, 1969.
  • 6
    Friis S, Storm HH. Urban-rural variation in cancer incidence on Denmark 1943–1987. Eur J Cancer. 1993; 29A: 538544.
  • 7
    Doll R. Urban and rural factors in the aetiology of cancer. Int J Cancer. 1991: 47: 803810.
  • 8
    Slattery ML, Overall JC Jr., Abbott TM, French TK, Robison LM, Gardner J. Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. Am J Epidemiol. 1989; 130: 248258.
  • 9
    Boon ME, de Graaff Guilloud JC, Olthof PM, van Erp EJ. Efficacy of screening for cervical squamous and adenocarcinoma: the Dutch experience. Cancer. 1987; 59: 862866.
  • 10
    Van Roon E, Boon ME, Kurver PJH. The association between precancerous columnar and squamous lesions of the cervix: a morphometric study. Histopathology. 1983; 7: 887896.
  • 11
    Boon ME, Ravenswaay Claasen HH van, Kok LP. Urbanization and baseline prevalence of genital infections including candida, trichomonas, and human papillomavirus, and of a disturbed vaginal ecology as established in the Dutch cervical screening program. Am J Obstet Gynecol. 2002; 187: 365369.
  • 12
    Rozendaal L, Westerga J, van der Linden JC, et al. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol. 2000; 53: 606611.
  • 13
    Milde-Langelosch K, Schreiber C, Becker G. Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Hum Pathol. 1993; 24: 590594.
  • 14
    Giacomini G, Calcinai A, Moretti D, Cristofani R. Accuracy of cervical/vaginal cytology in the diagnosis of bacterial vaginosis. Sex Trans Dis. 1998; 25: 2427.
  • 15
    Prey M. Routine Pap smears for the diagnosis of bacterial vaginosis. Diagn Cytopathol. 1999; 21: 1013.
  • 16
    Schnadig VJ, Davie KD, Shafer SK, Yandell RB, Islam MZ, Hannigan EV. The cytologist and bacteriosis of the vaginal-ectocervical area. Clues, commas, and confusion. Acta Cytol. 1989; 33: 287297.
  • 17
    Thorsen P, Jensen IP, Jeune B, et al. Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women. Am J Obstet Gynecol. 1998; 178: 580587.